Clinical repercussion of the 6th edition TNM staging system classification on differentiated thyroid carcinoma;Repercussão clínica da reclassificação dos carcinomas diferenciados de tireóide de acordo com a 6a edição do TNM

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 5, 2007, Pages 825-831

  Varandas, Vanessa M ^a   Coelho, Sabrina Mendes ^a   Soeiro, Ana Paula V ^a   Coeli, Cláudia Medina ^a,b   De Carvalho, Denise Pires ^a   Buescu, Alexandru ^a   Vaisman, Mário ^a,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Universidade Estadual Rio de Janeiro ^*  (Brazil)

Author keywords

Prognosis; Staging; Thyroid cancer

Indexed keywords

EID: 35348851974     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000500021     Document Type: Article

References (19)

1. Bland JM, Altman DG. Survival probabilities (the Kaplan-Meier method). BMJ 1998;317:1572-80.
2. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O'Sullivan B. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer 1997;15:2414-23.
3. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measurements 1960;20:37-46.
4. Denoix PF. Tumor, node, and metastasis (TNM). Bull Inst Nat Hyg 1944;1:1-69.
5. th edition TNM classification system in a retrospective analysis of 169 patients. Thyroid 2004;14:65-70.
6. Emerick GT, Duh QY, Siperstein AE, Burrow GN, Clark OH. Diagnosis, treatment and outcome of follicular thyroid carcinoma. Cancer 1993;72:3287-95.
7. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997;79:564-73.
8. Hamming JF, Van de Velde CJ, Goslings BM, Shelfhout LJ, Fleuren GJ, Hermans J. Prognosis and morbidity after total thyroidectomy for papillary and follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol 1989;25:1317-23.
9. Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PPB. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997;82:3553-62.
10. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999;9:421-7.
11. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
12. Reichenheim ME. Confidence intervals for the kappa statistic. Stata J 2004;4:421-8.
13. Schlumberger M. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306.
14. Schlumberger M, Pacini F. Thyroid tumors. Paris: Éditions Nucléon, 1999. p. 317.
15. Shrout PE. Measurement reliability and agreement in psychiatry. Stat Methods Med Res 1998;7:301-17.
16. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T. Papillary and follicular thyroid cancer - prognostic factors in 1,578 patients. Am J Med 1987;83:479-88.
17. th edition. New York: Wiley-Liss, 2002. pp. 52-6.
18. StataCorp. Stata Statistical Software: Release 8.0. College Station, TX: Stata Corporation, 2003.
19. Yildirim E. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. J Am Coll Surg 2005;200:378-92.